Quantitative variations of CD4+CD25+ cells in Peking duckwhite leghorn chimeras based on bone marrow mesenchymal stem cells
Purpose: To develop a chimera via microinjection of poultry xenogeneic bone marrow mesenchymal stem cells (BMMSCs), and to assess its immune tolerance based on variations in proportion of CD4+CD25+ cells in CD4+ cells (specific CD4+CD25+ cells).
Methods: BMMSCs were flush out from femurs and tibias of Peking ducks with phosphate-buffered saline and cultured. Their morphology was determined with a microscope. Several surface markers (i.e., CD44, CD45, CD71, CD73 and CD34) were used to identify the cells.
Results: The results indicate successful chimera development. CD4+CD25+ cells derived from the thymus of chimeras were migrated to the spleen and cecal tonsils. This migration was more obvious in chimeras than in the control group, suggesting a more robust immune system in the chimeras. The migration tendency gradually decreased with time. There were significant increases in specific CD4+CD25+ cells, TGF-β and IL-10 in cecal tonsils throughout the experimental period (30 days). However, in thymus and spleen, variations in specific CD4+CD25+ cells were observed only on the 1st day post-hatching.
Conclusion: The results suggest a relatively pure BMMSC population without contaminating hematopoietic stem cells. Differentiation of the BMMSCs into osteoblasts and adipocytes was inducible, indicating typical MSC character.
Keywords: Bone marrow mesenchymal stem cells, Immune tolerance, Chimera, Specific CD4+CD25+ cells, Cell migration
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.